Breaking News Instant updates and real-time market news.

LRCX

Lam Research

$96.17

1.34 (1.41%)

, KLAC

KLA-Tencor

$71.21

0.91 (1.29%)

07:23
10/06/16
10/06
07:23
10/06/16
07:23

Lam Research outlook still positive after merger terminated, says RBC Capital

After Lam Research (LRCX) and KLA-Tencor (KLAC) announced that their merger had been terminated, RBC Capital analyst Amit Daryanani remains upbeat on Lam's outlook as a standalone entity. He expects the company to benefit from strong 3D-NAND spending in 2017, and he keeps a $105 price target and Outperform rating on the stock.

LRCX

Lam Research

$96.17

1.34 (1.41%)

KLAC

KLA-Tencor

$71.21

0.91 (1.29%)

  • 06

    Oct

  • 19

    Oct

  • 18

    Nov

LRCX Lam Research
$96.17

1.34 (1.41%)

08/29/16
08/29/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. T-Mobile (TMUS) upgraded to Outperform from Market Perform at Wells Fargo, with analyst Jennifer Fritzsche saying the company's free cash flow should ramp significantly in 2017. T-Mobile should also see continued positive momentum in subscriber growth and be helped by M&A speculation post the Presidential election, said Fritzsche, who raised her price target range for the shares to $52-$54 from $48-$50. 2. KLA-Tencor (KLAC) upgraded to Outperform from Market Perform at Cowen by analyst Timothy Arcuri, who views the shares as "too interesting to ignore" regardless of the Lam Research (LRCX) deal outcome. KLA's risk/reward, even if the deal breaks, is now 3:1 to the upside, which is hard to find in semis, Arcuri tells investors in a research note. 3. Allegheny Technologies (ATI) upgraded to Buy from Hold at Deutsche Bank, with Deutsche Bank analyst Jorge Beristain saying leverage concerns have eased following the closure of the company's Rowley facility. Management is acting to exit low-margin stainless products, said Beristain. 4. CBL & Associates (CBL) upgraded to Buy from Hold at Jefferies, as analyst Omotayo Okusanya thinks "several issues" that have been an overhang on the shares are now resolved or are in the process of resolution. The company's portfolio quality is rising while its balance sheet is in better shape, Okusanya tells investors. 5. AstraZeneca upgraded to Buy from Hold at Argus. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/08/16
SBSH
09/08/16
NO CHANGE
Target $102
SBSH
Buy
Citi stil sees risk in Lam, KLA-Tencor merger deal
Dealreporter yesterday published an article yesterday stating that Lam Research (LRCX) is in discussions with China's MOFCOM to resolve deal concerns, Citi analyst Atif Malik tells investors in a research note. The analyst continues to see risk in Lam, KLA-Tencor (KLAC) deal on decreased competition concerns with regulators. He adds that equipment peers at the Citi Technology conference this week spoke of concentration concerns with the deal. Malik has a Buy rating on Lam with a $102 price target.
10/05/16
RBCM
10/05/16
NO CHANGE
RBCM
Micron report reads positively for Applied Materials, Lam, says RBC Capital
Following Micron's (MU) quarterly report and guidance, RBC Capital Amit Daryanani said he sees positive read-through from the report for Applied Materials (AMAT), Lam Research (LRCX), ASML (ASML), Western Digital (WDC) and Intel (INTC). Micron management expects capex spending of $4.8B-$5.2B for FY17, noted Daryanani, who believes continued 3D NAND spending will benefit Applied and Lam the most.
10/06/16
RILY
10/06/16
UPGRADE
Target $86
RILY
Buy
KLA-Tencor upgraded to Buy from Neutral at B. Riley
B. Riley analyst Craig Ellis upgraded KLA-Tencor (KLAC) to Buy and raised his price target for the shares to $86 from $78 after the company discontinued its proposed merger with Lam Research (LRCX).
KLAC KLA-Tencor
$71.21

0.91 (1.29%)

09/13/16
FBCO
09/13/16
UPGRADE
Target $85
FBCO
Outperform
KLA-Tencor upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Farham Ahmad upgraded KLA-Tencor (KLAC) to Outperform and raised its price target to $85 from $82. Ahmad does not expect the Lam Research (LRCX) merger to go through but views KLA-Tencor as attractive on a standalone valuations. The analyst's FY17 earnings estimate of $5.34 is 11% above the Street, and he sees potential for multiple expansion driven by OpM and 3% dividend yield.
10/03/16
FBCO
10/03/16
NO CHANGE
Target $85
FBCO
Outperform
KLA-Tencor added to US Focus List at Credit Suisse
Credit Suisse analyst Farhan Ahmad added KLA-Tencor to the US Focus List and reiterated his views that shares are very attractive in near term given upside his estimates, 2H 2016/CY17 earnings are 10%/7% above Street. The analyst has greater conviction that stock is already pricing in the breakup of the proposed Lam Research (LRCX) merger following meetings and calls with investors over the last few weeks, and sees significant interest in KLA-Tencor shares from investors. Ahmad commented on investor concerns and thinks Gen 5 will take share from Ebeam inspection, Foundry 28nm capex from China could be a 2018 growth driver, and believes valuation reflects the merger and sees upside expansion to the multiple. Ahmad rates KLA-Tencor an Outperform with an $85 price target.

TODAY'S FREE FLY STORIES

SHOO

Steven Madden

$48.20

-0.1 (-0.21%)

12:21
01/16/18
01/16
12:21
01/16/18
12:21
Hot Stocks
Steve Madden reports 7.52% stake in Steven Madden »

Steven Madden…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TER

Teradyne

$45.45

0.8494 (1.90%)

12:20
01/16/18
01/16
12:20
01/16/18
12:20
Options
Notable call buying in Teradyne ahead of earnings »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

MRK

Merck

$62.74

4.081 (6.96%)

, GE

General Electric

$18.09

-0.67 (-3.57%)

12:18
01/16/18
01/16
12:18
01/16/18
12:18
General news
On The Fly: Top stock stories at midday »

Stocks opened sharply…

MRK

Merck

$62.74

4.081 (6.96%)

GE

General Electric

$18.09

-0.67 (-3.57%)

UNH

UnitedHealth

$234.15

5.51 (2.41%)

QCOM

Qualcomm

$65.38

-0.05 (-0.08%)

AVGO

Broadcom

$264.29

0.79 (0.30%)

NXPI

NXP Semiconductors

$119.58

0.33 (0.28%)

GM

General Motors

$45.03

0.955 (2.17%)

UA

Under Armour; also tag UAA

$13.12

-1.025 (-7.25%)

UAA

Under Armour; also tag UA

$14.21

-0.915 (-6.05%)

SCOR

comScore

$29.10

0.305 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

  • 16

    Jan

  • 18

    Jan

  • 24

    Jan

  • 25

    Jan

  • 02

    Feb

  • 06

    Feb

  • 08

    Feb

  • 06

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 23

    Oct

$NSD

NASDAQ Market Internals

12:17
01/16/18
01/16
12:17
01/16/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
01/16/18
01/16
12:16
01/16/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOV

National Oilwell

$38.90

-0.24 (-0.61%)

12:15
01/16/18
01/16
12:15
01/16/18
12:15
Options
National Oilwell put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

DPW

DPW Holdings

$2.41

-0.325 (-11.90%)

12:12
01/16/18
01/16
12:12
01/16/18
12:12
Hot Stocks
DPW Holdings falls almost 12% after announcing conversion of notes »

Sandstone Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBOW

SilverBow Resources

$31.88

-0.9386 (-2.86%)

12:10
01/16/18
01/16
12:10
01/16/18
12:10
Conference/Events
SilverBow Resources management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCEHY

Tencent

$56.92

1.565 (2.83%)

12:07
01/16/18
01/16
12:07
01/16/18
12:07
Hot Stocks
LEGO Group, Tencent form partnership in China »

The LEGO Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$101.32

0.35 (0.35%)

12:06
01/16/18
01/16
12:06
01/16/18
12:06
Hot Stocks
American Express reports December net write-off rate 2.0% vs. 1.9% last month »

Reports December 30-plus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

BX

Blackstone

$35.81

0.42 (1.19%)

12:05
01/16/18
01/16
12:05
01/16/18
12:05
Options
Blackstone call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

ICBK

County Bancorp

$30.16

0.38 (1.28%)

, MTW

Manitowoc

$40.09

0.73 (1.85%)

12:04
01/16/18
01/16
12:04
01/16/18
12:04
Hot Stocks
ICB to purchase Manitowoc Company headquarters »

Investors Community Bank,…

ICBK

County Bancorp

$30.16

0.38 (1.28%)

MTW

Manitowoc

$40.09

0.73 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$31.78

0.405 (1.29%)

12:02
01/16/18
01/16
12:02
01/16/18
12:02
Hot Stocks
Roche launches CE-marked VENTANA MMR IHC Panel »

Roche announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 23

    Feb

NSRGY

Nestle

$85.10

0.58 (0.69%)

12:02
01/16/18
01/16
12:02
01/16/18
12:02
Hot Stocks
Nestle agrees to sell U.S. confectionery business to Ferrero »

Nestle announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HES

Hess Corp.

$54.16

-0.38 (-0.70%)

12:00
01/16/18
01/16
12:00
01/16/18
12:00
Periodicals
Hess to cut hundreds of jobs as it battles activist shareholder, Reuters says »

Hess plans to lay off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

CECE

CECO Environmental

$5.22

-0.07 (-1.32%)

12:00
01/16/18
01/16
12:00
01/16/18
12:00
Hot Stocks
CECO Environmental reports award of 'large contract' to energy business »

CECO Environmental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 17

    Jan

INFO

IHS Markit

$47.85

0.39 (0.82%)

11:55
01/16/18
01/16
11:55
01/16/18
11:55
Conference/Events
IHS Markit management to meet with RBC Capital »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

GSK

GlaxoSmithKline

$37.74

0.24 (0.64%)

11:54
01/16/18
01/16
11:54
01/16/18
11:54
Upgrade
GlaxoSmithKline rating change  »

GlaxoSmithKline upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 25

    Mar

GSK

GlaxoSmithKline

$37.76

0.2646 (0.71%)

11:51
01/16/18
01/16
11:51
01/16/18
11:51
Upgrade
GlaxoSmithKline rating change  »

GlaxoSmithKline upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 25

    Mar

SPY

SPDR S&P 500 ETF Trust

$278.99

1.07 (0.39%)

, SPX

S&P 500

11:50
01/16/18
01/16
11:50
01/16/18
11:50
Periodicals
Steve Bannon subpoenaed before grand jury by Mueller, NY Time says »

Special counsel Robert…

SPY

SPDR S&P 500 ETF Trust

$278.99

1.07 (0.39%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$11.67

0.1978 (1.72%)

11:50
01/16/18
01/16
11:50
01/16/18
11:50
Options
Large spreads in Petrobras as shares reach 52-week highs »

Large spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$62.38

3.72 (6.34%)

11:45
01/16/18
01/16
11:45
01/16/18
11:45
Options
Merck call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 02

    Feb

  • 08

    Feb

  • 25

    Mar

  • 03

    Apr

  • 23

    Oct

11:45
01/16/18
01/16
11:45
01/16/18
11:45
General news
Treasury's $90 B bill auction were mixed, with the 3-month outperforming »

Treasury's $90 B…

TTMI

TTM Technologies

$17.39

0.59 (3.51%)

11:45
01/16/18
01/16
11:45
01/16/18
11:45
Conference/Events
TTM Technologies management to meet with SunTrust »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 17

    Jan

11:40
01/16/18
01/16
11:40
01/16/18
11:40
General news
U.S. VIX equity volatility is up nearly 10% »

U.S. VIX equity…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.